Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: MCK

McKesson Corporation

Healthcare | Medical - Distribution

Market prices for MCK are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$37.28

McKesson Corporation (NYSE: MCK) is a medical distributor. Figures from SEC EDGAR; updated 2026-10-18 12:38 UTC.

What McKesson Corporation does

McKesson Corporation is a diversified healthcare services company with roots dating to 1833 that partners with biopharma companies, care providers, pharmacies, manufacturers, and governments to deliver products and services across the healthcare system. The company operates through four reportable segments: North American Pharmaceutical, which distributes pharmaceutical drugs and healthcare products to customers in the United States and Canada; Oncology Multispecialty, which provides specialty drug distribution, group purchasing organizations, infusion services, and supports a network of commu…

Summarized from McKesson Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$37.28
Return on equity-219.24%

Revenue, margins & earnings

FY2022 Operating expenses: $11.1BFY2022 Cost of revenue: $250.8B$264.0BFY2022FY2023 Net income: $3.56BFY2023 Operating expenses: $7.98BFY2023 Cost of revenue: $264.4B$276.7BFY2023FY2024 Operating expenses: $8.92BFY2024 Cost of revenue: $296.1B$309.0BFY2024FY2025 Net income: $3.29BFY2025 Operating expenses: $8.90BFY2025 Cost of revenue: $345.7B$359.1BFY2025FY2026 Net income: $4.76BFY2026 Operating expenses: $8.34BFY2026 Cost of revenue: $388.9B$403.4BFY2026
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-10
  • 2026-09-10SVP, Controller & CAOSale-111$99.0K
  • 2026-08-11DirectorSale-301$268.6K
  • 2026-08-11EVP and Chief Strategy OfficerRestricted Stock Units (RSUs)Award368—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does McKesson Corporation do?

McKesson Corporation is a diversified healthcare services company with roots dating to 1833 that partners with biopharma companies, care providers, pharmacies, manufacturers, and governments to deliver products and services across the healthcare system.

When did MCK last file with the SEC?

McKesson Corporation's most recent SEC filing on record is a 8-K filed 2026-10-06. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-18 12:38 UTC. This page is also available as JSON at /api/data?ticker=MCK and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for MCK and 5,000+ tickers.

Create a free account — keep MCK
For your agent
GET /api/data?ticker=MCK

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt